U.S. markets open in 8 hours 51 minutes
  • S&P Futures

    4,216.25
    +6.50 (+0.15%)
     
  • Dow Futures

    33,346.00
    +42.00 (+0.13%)
     
  • Nasdaq Futures

    13,342.75
    +31.50 (+0.24%)
     
  • Russell 2000 Futures

    1,980.50
    +4.20 (+0.21%)
     
  • Crude Oil

    93.85
    -0.49 (-0.52%)
     
  • Gold

    1,807.80
    +0.60 (+0.03%)
     
  • Silver

    20.34
    -0.01 (-0.04%)
     
  • EUR/USD

    1.0323
    -0.0002 (-0.02%)
     
  • 10-Yr Bond

    2.8880
    0.0000 (0.00%)
     
  • Vix

    20.20
    +0.46 (+2.33%)
     
  • GBP/USD

    1.2196
    -0.0006 (-0.05%)
     
  • USD/JPY

    133.1500
    +0.1510 (+0.11%)
     
  • BTC-USD

    23,982.32
    -343.66 (-1.41%)
     
  • CMC Crypto 200

    570.05
    -4.69 (-0.82%)
     
  • FTSE 100

    7,465.91
    -41.20 (-0.55%)
     
  • Nikkei 225

    28,483.30
    +663.97 (+2.39%)
     

U.S. FDA authorizes Novavax COVID vaccine for adults

In this article:
  • Oops!
    Something went wrong.
    Please try again later.

July 13 (Reuters) - The U.S. Food and Drug Administration authorized the use of Novavax Inc's COVID-19 vaccine on Wednesday, clearing the way for a shot whose more traditional technology has raised hopes of wider acceptance among vaccine skeptics.

It is the fourth COVID vaccine to be authorized for use in adults in the United States. (Reporting by Manas Mishra in Bengaluru; Editing by Vinay Dwivedi and Devika Syamnath)